Search Results - "Merikhian, Parnaz"

Triple-negative breast cancer: understanding Wnt signaling in drug resistance by Merikhian, Parnaz, Eisavand, Mohammad Reza, Farahmand, Leila

“…Abstract Triple-negative breast cancer (TNBC) is not as prevalent as hormone receptor or HER2-positive breast cancers and all receptor tests come back…”
Get full text

Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling by Khodabakhsh, Farnaz, Merikhian, Parnaz, Eisavand, Mohammad Reza, Farahmand, Leila

“…VEGF and its receptor family (VEGFR) members have unique signaling transduction system that play significant roles in most pathological processes, such as…”
Get full text

MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy by Hosseinzadeh, Aysooda, Merikhian, Parnaz, Naseri, Nazanin, Eisavand, Mohammad Reza, Farahmand, Leila

“…Although resistance is its major obstacle in cancer therapy, trastuzumab is the most successful agent in treating epidermal growth factor receptor 2 positive…”
Get full text

Monoclonal antibody‐based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER by Moradi‐Kalbolandi, Shima, Hosseinzade, Aysooda, Salehi, Malihe, Merikhian, Parnaz, Farahmand, Leila

“…Objectives Monoclonal antibody‐based of cancer therapy has been considered as one of the most successful therapeutic strategies for both haematologic…”
Get full text

Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors by Merikhian, Parnaz, Darvishi, Behrad, Jalili, Neda, Esmailinejad, Mohammad Reza, Khatibi, Azadeh Sharif, Kalbolandi, Shima Moradi, Salehi, Malihe, Mosayebzadeh, Marjan, Barough, Mahdieh Shokrollahi, Majidzadeh‐A, Keivan, Yadegari, Fatemeh, Rahbarizadeh, Fatemeh, Farahmand, Leila

“…Alteration in glycosylation pattern of MUC1 mucin tandem repeats during carcinomas has been shown to negatively affect adhesive properties of malignant cells…”
Get full text

Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk by Barzaman, Khadijeh, Vafaei, Rana, Samadi, Mitra, Kazemi, Mohammad Hossein, Hosseinzadeh, Aysooda, Merikhian, Parnaz, Moradi-Kalbolandi, Shima, Eisavand, Mohammad Reza, Dinvari, Houra, Farahmand, Leila

“…Abstract As an intelligent disease, tumors apply several pathways to evade the immune system. It can use alternative routes to bypass intracellular signaling…”
Get full text

MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer by Merikhian, Parnaz, Ghadirian, Reyhane, Farahmand, Leila, Mansouri, Sepideh, Majidzadeh-A, Keivan

“…Introduction: Tamoxifen, as an essential therapeutic tool in the treatment of estrogen receptor-positive breast cancer, has been available for the past three…”
Get full text